Transcriptional regulation of the p53 tumor suppressor gene

By Reisman D.   Loging W.T.  

Seminars in Cancer Biology, Vol. 8, Iss. 5, 1997-10 ,pp. : 317-324

Academic Press

Access to resources Recommend Favorite

Potential of Advexin^®®: a p53 gene-replacement therapy in Li––Fraumeni syndrome

By Nemunaitis Jackie M   Nemunaitis John  

Future Oncology, Vol. 4, Iss. 6, 2008-12 ,pp. : 759-768

Future Medicine

Access to resources Recommend Favorite

Activation of p53 by Specific Agents in Potential Cancer Therapy

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 2, 2005-03 ,pp. : 131-135

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation of p53 target gene expression by cisplatin-induced extracellular signal-regulated kinase

By DeHaan Ryan   Yazlovitskaya Eugenia   Persons Diane  

Cancer Chemotherapy and Pharmacology, Vol. 48, Iss. 5, 2001-11 ,pp. : 383-388

Springer Publishing Company

Access to resources Recommend Favorite

Down-regulation of Wilms’ tumor 1 expression in glioblastoma cells increases radiosensitivity independently of p53

By Clark Aaron   Chan Dana   Chen Mike   Fillmore Helen   Dos Santos Wagner   Meter Timothy   Graf Martin   Broaddus William  

Journal of Neuro-Oncology, Vol. 83, Iss. 2, 2007-06 ,pp. : 163-172

Springer Publishing Company

Access to resources Recommend Favorite